Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Tominaga, T.; Dutta, R.K.; Joladarashi, D.; Doi, T.; Reddy, J.K.; Kanwar, Y.S.
    Transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids implications in renal tubular injury induced in obesity and diabetes (2016), J. Biol. Chem., 291, 1348-1367 .
    View publication on PubMedView publication on EuropePMC

Activating Compound

EC Number Activating Compound Comment Organism Structure
1.13.99.1 palmitate concomitant treatment with palmitate/bovine serum albumin and activators of PKA (forskolin), PDK/PI3K (insulin), and PKC (TPA) increase Miox activity. Concomitant treatment with respective inhibitors, i.e. H89 (PKA), wortmannin (PI3K), and calphostin (PKC), reduces the activity below the levels induced by palmitate/bovine serum albumin alone, confirming that fatty acid-induced activity is phosphorylation-dependent Sus scrofa

Cloned(Commentary)

EC Number Cloned (Comment) Organism
1.13.99.1 gene MIOX, quantitative real-time PCR enzyme expression analysis Mus musculus
1.13.99.1 gene MIOX, quantitative real-time PCR enzyme expression analysis Rattus norvegicus
1.13.99.1 gene MIOX, quantitative real-time PCR enzyme expression analysis Homo sapiens
1.13.99.1 gene MIOX, quantitative real-time PCR enzyme expression analysis Sus scrofa

Localization

EC Number Localization Comment Organism GeneOntology No. Textmining
1.13.99.1 mitochondrion
-
Mus musculus 5739
-
1.13.99.1 mitochondrion
-
Rattus norvegicus 5739
-
1.13.99.1 mitochondrion
-
Homo sapiens 5739
-
1.13.99.1 mitochondrion
-
Sus scrofa 5739
-

Natural Substrates/ Products (Substrates)

EC Number Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
1.13.99.1 myo-inositol + O2 Mus musculus
-
D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2 Rattus norvegicus
-
D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2 Homo sapiens
-
D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2 Sus scrofa
-
D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2 Mus musculus CD1
-
D-glucuronate + H2O
-
?

Organism

EC Number Organism UniProt Comment Textmining
1.13.99.1 Homo sapiens Q9UGB7
-
-
1.13.99.1 Mus musculus Q9QXN5
-
-
1.13.99.1 Mus musculus CD1 Q9QXN5
-
-
1.13.99.1 Rattus norvegicus Q9QXN4
-
-
1.13.99.1 Sus scrofa Q8WN98
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
1.13.99.1 HK-2 cell
-
Homo sapiens
-
1.13.99.1 kidney
-
Mus musculus
-
1.13.99.1 kidney
-
Rattus norvegicus
-
1.13.99.1 kidney
-
Homo sapiens
-
1.13.99.1 kidney
-
Sus scrofa
-
1.13.99.1 LLC-PK1 cell
-
Sus scrofa
-
1.13.99.1 additional information immunohistochemic analysis Mus musculus
-
1.13.99.1 additional information immunohistochemic analysis Rattus norvegicus
-
1.13.99.1 additional information immunohistochemic analysis Homo sapiens
-
1.13.99.1 additional information immunohistochemic analysis Sus scrofa
-
1.13.99.1 renal tubule MIOX is a tubular-specific enzyme Mus musculus
-
1.13.99.1 renal tubule MIOX is a tubular-specific enzyme Rattus norvegicus
-
1.13.99.1 renal tubule MIOX is a tubular-specific enzyme Homo sapiens
-
1.13.99.1 renal tubule MIOX is a tubular-specific enzyme Sus scrofa
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
1.13.99.1 myo-inositol + O2
-
Mus musculus D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2
-
Rattus norvegicus D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2
-
Homo sapiens D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2
-
Sus scrofa D-glucuronate + H2O
-
?
1.13.99.1 myo-inositol + O2
-
Mus musculus CD1 D-glucuronate + H2O
-
?

Synonyms

EC Number Synonyms Comment Organism
1.13.99.1 MIOX
-
Mus musculus
1.13.99.1 MIOX
-
Rattus norvegicus
1.13.99.1 MIOX
-
Homo sapiens
1.13.99.1 MIOX
-
Sus scrofa
1.13.99.1 Myo-inositol oxygenase
-
Mus musculus
1.13.99.1 Myo-inositol oxygenase
-
Rattus norvegicus
1.13.99.1 Myo-inositol oxygenase
-
Homo sapiens
1.13.99.1 Myo-inositol oxygenase
-
Sus scrofa

Temperature Optimum [°C]

EC Number Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
1.13.99.1 37
-
assay at Mus musculus
1.13.99.1 37
-
assay at Rattus norvegicus
1.13.99.1 37
-
assay at Homo sapiens
1.13.99.1 37
-
assay at Sus scrofa

pH Optimum

EC Number pH Optimum Minimum pH Optimum Maximum Comment Organism
1.13.99.1 8
-
assay at Mus musculus
1.13.99.1 8
-
assay at Rattus norvegicus
1.13.99.1 8
-
assay at Homo sapiens
1.13.99.1 8
-
assay at Sus scrofa

Expression

EC Number Organism Comment Expression
1.13.99.1 Mus musculus transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids, overview additional information
1.13.99.1 Rattus norvegicus transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids, overview additional information
1.13.99.1 Homo sapiens transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids, overview additional information
1.13.99.1 Sus scrofa transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids, overview additional information
1.13.99.1 Mus musculus administration of high-fat diet to CD1 mice over a period of 2-6 weeks induces a tremendous increase in the expression of Miox, exclusively confined to the tubular compartment of the kidney cortex. Besides the increased expression in superficial cortical tubules, it also extends into the deeper cortex. Upregulation of Miox is accompanied by upregulation of mSrebp1 in kidney cells. Rapamycin reverses palmitate/bovine serum albumin-induced Miox, Srebp1, and p53 expression and apoptosis in renal tubular cells up
1.13.99.1 Rattus norvegicus high-fat diet administration over a period of 6 weeks results in a marked time-dependent up-regulation of Miox up
1.13.99.1 Sus scrofa palmitate-conjugated bovine serum albumin causes a dose-dependent increase in Miox expression and activity in LLCPK-1 cells. Concomitant with Miox upregulation, a dose-dependent increased Bax protein expression is observed following palmitate/BSA treatment of LLCPK-1 cells. Concomitant treatment with palmitate/bovine serum albumin and activators of PKA (forskolin), PDK/PI3K (insulin), and PKC (TPA) further increase Miox activity up
1.13.99.1 Homo sapiens treatment of HK-2 cells with palmitate/bovine serum albumin for 24 h induces an increased Miox expression with a concomitant decrease in the membrane-bound precursor form of pre-Srebp1 in the cytoplasmic fraction. No change in the expression of beta-actin or laminB1 is observed. Miox is transcriptionally upregulated by high glucose ambience. A dose-dependent increase in the expression of Miox is observed following insulin treatment. At the same time, a dose-dependent increase in the mSrebp1 is observed. Rapamycin reverses palmitate/bovine serum albumin-induced Miox, Srebp1, and p53 expression and apoptosis in renal tubular cells up